Goat serum-derived polyclonal antibodies

Drug Profile

Goat serum-derived polyclonal antibodies

Alternative Names: Aimspro; Caprine hyperimmune serum; Caprivax; Ceremben; Goat serum derived product; HICS; Hyperimmune caprine serum; Hyperimmune goat serum product

Latest Information Update: 23 Jun 2015

Price : $50

At a glance

  • Originator Daval International
  • Class Immunoglobulins; Polyclonal antibodies; Serum globulins
  • Mechanism of Action Corticotropin-releasing hormone stimulants; Immunomodulators; Sodium channel modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Systemic scleroderma; Amyotrophic lateral sclerosis; Globoid cell leukodystrophy
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Phase II Amyotrophic lateral sclerosis; Multiple sclerosis; Systemic scleroderma

Most Recent Events

  • 23 Jun 2015 Aimspro® is still in active development for Multiple sclerosis and Systemic scleroderma in United Kingdom
  • 23 Jun 2015 Aimspro® is still in active development for Amyotrophic lateral sclerosis in Australia and United Kingdom
  • 25 Feb 2014 Goat serum-derived polyclonal antibodies receives Orphan Drug status for Systemic scleroderma in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top